!%Hologenix LLC%!, maker of the therapeutic Celliant textile technology, has completed its science advisory board with the appointment of Dr. Michael R. Hamblin, principal investigator at the Wellman Center for Photomedicine at Massachusetts General Hospital in Cambridge and an associate professor of dermatology at Harvard Medical School. He is also a member of the affiliated faculty of the Harvard-MIT Div. of Health Science and Technology. Based in Santa Monica, Calif., the company also has established an R&D laboratory.